Photo taken from Karl Semaan/X
Aug 16, 2024, 14:16
Karl Semaan: First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma
Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“Just in European Urology, our study on first-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma.
Effort co-led with Talal El Zarif with amazing mentorship from Daniel Heng and Toni Choueiri.”
Source: Karl Semaan/X
Authors: Talal El Zarif, Karl Semaan, Wanling Xie, Marc Eid, Martin Zarba, Wadih Issa, Tian Zhang, Charles B. Nguyen, Ajjai Alva, Catherine C. Fahey, Kathryn E. Beckermann, Jose A. Karam, Matthew T. Campbell, Giuseppe Procopio, Marco Stellato, Sebastiano Buti, Anezka Zemankova, Bohuslav Melichar, Francesco Massari, Veronica Mollica, and Toni K. Choueiri.
adjuvant immunotherapy
Ajjai Alva
Anezka Zemankova
Bohuslav Melichar
cancer
Catherine C. Fahey
Charles B. Nguyen
Daniel Heng
european urology
Francesco Massari
Giuseppe Procopio
Jose A. Karam
Karl Semaan
Kathryn E. Beckermann
Marc Eid
Marco Stellato
Martin Zarba
Matthew T Campbell
OncoDaily
Oncology
renal cell carcinoma
Sebastiano Buti
Talal El Zarif
Tian Zhang
Toni Choueiri
Toni K. Choueiri
Veronica Mollica
Wadih Issa
Wanling Xie